TransMedics Group, Inc. TMDX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Heart Product | $30.87M+3.1% | $29.94M-2.1% | $30.59M-14.2% | $35.67M+19.6% | $29.82M+6.0% | |
| Liver Product | $138.98M+8.9% | $127.63M+18.2% | $107.94M-7.0% | $116.11M+6.7% | $108.86M+22.3% | |
| Lung Product | $2.82M+30.4% | $2.17M-47.3% | $4.11M-10.2% | $4.58M+14.1% | $4.01M+17.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does TransMedics Group, Inc. break its business down?
- TransMedics Group, Inc. (TMDX) reports revenue by product across 3 parts — Heart Product, Liver Product and Lung Product. Each is extracted from the segment footnotes and tracked over time.
- Where does TransMedics Group, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in TransMedics Group, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
